Bausch Health Companies Inc (NYSE:BHC) currently has a daily average trading volume of 2.31M but it saw 6293140 shares traded in last market. With a market cap of 3.83B USD, the company’s current market price of $10.49 came rising about 6.39 while comparing to the previous closing price of $9.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.15 and as low as $5.57.
Taking a look at 20-day trading activity of Bausch Health Companies Inc (BHC) gives us an average price of $9.47, while its current price level is 3.40% below from 52-week high level whereas it is 88.32% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $8.81 while that of 200 days or SMA-200 reads an average of $8.15. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.91% during that period while stretching the period over a month that decreases to 3.30%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 75.03 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which upgraded the stock as “Buy” in its note to investors issued on September 20, 2023, recommending a price target of between $9 and $16 for it.
Over the week, BHC’s stock price is moving 9.38% up while it is 14.27% when we observe its performance for the past one month. Year-to-date it is 30.80% up and over the past year, the stock is showing an upside performance of 40.81%.
The latest quarterly earnings report issued by the company was for quarter ended 12/30/2023, when its quarterly earnings per share (EPS) of $1.15 beat the consensus estimate of $1.02 for the same. For BHC, analysts are forecasting an EPS-growth rate of 12.60% for current year and estimate for EPS growth in next year is 1.50%. In next quarter, company is expected to be making quarterly sales of $2.35 billion as analysts are expecting the sales for current fiscal year at $9.39 billion and seeing the company making $9.44 billion in sales next year. Moreover, analysts are in estimates of $2.15 billion for current-quarter revenue.
Currently, Bausch Health Companies Inc’s total number of outstanding shares is 365.24M with 8.18% of that held by the insiders while 81.00% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -2.81%. It has a 2.63 of forward P/E ratio. Stock’s beta reads 0.84. Stock has a price to sale or P/S ratio amounts to 0.44. Its return on asset (ROA) is -2.23% on average.
